A Pilot Phase II Double Blind Placebo Controlled Dose Finding and Tolerability Study of Isradipine as a Disease Modifying Agent in Patients with Early Parkinson's

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/0812/31/13

Funding

  • Northwestern Memorial Foundation (Signed Agmt 4/30/08)